title: Improvement of cardiac function, mitral regurgitation and pulmonary hypertension in a patient with chronic eosinophilic leukemia (CEL) after low dose imatinib therapy.
authors.forename: Maria-Theresa
authors.initials: MT
authors.lastname: Krauth
authors.forename: Thomas
authors.initials: T
authors.lastname: Binder
authors.forename: Leopold
authors.initials: L
authors.lastname: Ohler
authors.forename: Ulrich
authors.initials: U
authors.lastname: Jäger
authors.forename: Peter
authors.initials: P
authors.lastname: Valent
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D006333:Heart Failure / Q000175:diagnosis / Q000517:prevention & control*; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy*; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000517:prevention & control*; D000068877:Imatinib Mesylate; D008297:Male; D008944:Mitral Valve Insufficiency / Q000175:diagnosis / Q000517:prevention & control*; D010879:Piperazines / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases